CD274 and neoplasm: However, 3/6 mice treated with CAR + dSHP2 displayed delayed tumor growth followed by rejection in the later stages of the model and were still alive at day 31 (Figure 4D) indicating the dSHP2 was able to counter the suppressive effect of PDL1 and enhance mouse survival and CAR T function in this context.